An integrated epigenome and transcriptome analysis identifies PAX2 as a master regulator of drug resistance in high grade pancreatic ductal adenocarcinoma-Reference-Cited by-同舟云学术

An integrated epigenome and transcriptome analysis identifies PAX2 as a master regulator of drug resistance in high grade pancreatic ductal adenocarcinoma

Published:2019-10-17 Issue:10 Volume:14 Page:e0223554
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Aier Imlimaong,Semwal Rahul,Dhara Aiindrila,Sen Nirmalya,Varadwaj Pritish Kumar^ORCID

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference90 articles.

1. Cancer statistics, 2016;RL Siegel;CA: a cancer journal for clinicians,2016

2. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States;L Rahib;Cancer research,2014

3. A systematic assessment of statistics, risk factors, and underlying features involved in pancreatic cancer;I Aier;Cancer epidemiology,2019

4. Pancreatic cancer cells resistant to chemoradiotherapy rich in "stem-cell-like" tumor cells;Z Du;Digestive diseases and sciences,2011

5. Pancreatic cancer;D Li;Lancet,2004

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PAX2 mediated upregulation of ESPL1 contributes to cisplatin resistance in bladder cancer through activating the JAK2/STAT3 pathway;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-04-04

2. Assessment of spatial transcriptomics for oncology discovery;Cell Reports Methods;2022-11

3. Analysis of Transcriptomic Data Generated from Drug-Treated Cancer Cell Line;Methods in Molecular Biology;2022

4. Stem/progenitor cells in normal physiology and disease of the pancreas;Molecular and Cellular Endocrinology;2021-12

5. Suppression of pancreatic ductal adenocarcinoma growth and metastasis by fibrillar collagens produced selectively by tumor cells;Nature Communications;2021-04-20